Tag Archives: 2019

Weekly Roundup for MARCH 1, 2019: Recent Publications in Women’s Mental Health

This week there are a series of articles related to the recommendations issued by the US Preventive Services Task Force (USPSTF) several weeks ago, stating that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and recommends that women at increased risk for perinatal depression should be referred… Read More »

Mylan quarterly profit, 2019 forecast miss Wall Street estimates — stock tanks

Generic drugmaker Mylan on Tuesday reported lower-than-expected fourth-quarter profit and forecast 2019 earnings well below Wall Street estimates, as it grapples with significant problems at its Morgantown, West Virginia, plant. Mylan said the lower forecast was due to higher projected sales, marketing and research and development costs, and its shares fell about 10 percent. Mylan… Read More »

Weekly Roundup for FEBRUARY 1, 2019: Recent Publications in Women’s Mental Health

Over the last few years, there has been an increasing number of articles focusing on perinatal anxiety.  Recent studies indicate that anxiety during pregnancy and the postpartum period is common and may occur independently of perinatal depression, although anxiety and depressive symptoms frequently appear together during the perinatal period.  This week we have several large… Read More »